prazosin has been researched along with Urinary Retention in 16 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This prospective randomized double-blinded clinical trial was designed to explore the effects of amlodipine and the combination of amlodipine with terazosin in improving postvoid residual (PVR) in patients with lower urinary tract symptoms (LUTS) and concomitant hypertension." | 9.14 | [Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention]. ( Fang, J; Li, YL; Liu, HP; Qin, XH; Xu, XP; Yang, C; Zhang, X, 2009) |
| "Terazosin, a selective, long-acting alpha 1-adrenergic blocker, was evaluated in 44 men with benign prostatic hyperplasia." | 9.07 | Efficacy of terazosin in patients with benign prostatic hyperplasia. ( Laddu, A; Matzkin, H; Rangel, MC; Soloway, MS, 1992) |
| "Acute urinary retention is a frequent complication following inguinal hernia repair." | 6.68 | A placebo controlled double blind study using perioperative prazosin in the prevention of urinary retention following inguinal hernia repair. ( Carmalt, HL; Woo, HH, 1995) |
| "This prospective randomized double-blinded clinical trial was designed to explore the effects of amlodipine and the combination of amlodipine with terazosin in improving postvoid residual (PVR) in patients with lower urinary tract symptoms (LUTS) and concomitant hypertension." | 5.14 | [Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention]. ( Fang, J; Li, YL; Liu, HP; Qin, XH; Xu, XP; Yang, C; Zhang, X, 2009) |
| "Terazosin, a selective, long-acting alpha 1-adrenergic blocker, was evaluated in 44 men with benign prostatic hyperplasia." | 5.07 | Efficacy of terazosin in patients with benign prostatic hyperplasia. ( Laddu, A; Matzkin, H; Rangel, MC; Soloway, MS, 1992) |
| "To evaluate the use and problems of alpha-receptor blockade with prazosin among patients in Nigeria with benign prostatic hyperplasia (BPH) who face a prolonged wait for a prostatectomy." | 3.69 | alpha-receptor blockade for benign prostatic hyperplasia: uses and problems in a developing country. ( Ogbonna, BC; Okeahialam, BN; Ramyil, VM, 1997) |
| "Once-daily dosing of TAM after breakfast at a fixed dose level (0." | 2.69 | A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. ( de Mey, C; McEwen, J; Michel, MC; Moreland, T, 1998) |
| "Acute urinary retention is a frequent complication following inguinal hernia repair." | 2.68 | A placebo controlled double blind study using perioperative prazosin in the prevention of urinary retention following inguinal hernia repair. ( Carmalt, HL; Woo, HH, 1995) |
| "Alternative treatments for benign prostatic hyperplasia (BPH) are the source of much discussion at present." | 2.67 | Comparative study of selective alpha 1-adrenoceptor blockade versus surgery in the treatment of prostatic obstruction. ( Chapple, CR; Milroy, EJ; Noble, JG, 1993) |
| "Urinary retention is the most common complication after anorectal surgery, with rates as high as 52 percent reported." | 2.67 | Does alpha sympathetic blockade prevent urinary retention following anorectal surgery? ( Cataldo, PA; Senagore, AJ, 1991) |
| " Only one of these could be managed satisfactorily by long-term administration of prazosin, carbachol and antibiotics, and the others had to be euthanased." | 1.30 | Idiopathic detrusor-urethral dyssynergia in dogs: a retrospective analysis of 22 cases. ( Díaz Espiñeira, MM; Nickel, RF; Viehoff, FW, 1998) |
| "Thus, functional bladder neck obstruction was considered to be responsible for obstructive voiding in these patients." | 1.29 | Functional bladder neck obstruction: a rare cause of renal failure. ( Banerjee, GK; Bhandari, M; Goel, MC; Kapoor, R; Kumar, A; Mishra, VK, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, KH | 1 |
| Aulakh, KS | 1 |
| Liu, C | 1 |
| Patel, DN | 1 |
| Felder, SI | 1 |
| Luu, M | 1 |
| Daskivich, TJ | 1 |
| N Zaghiyan, K | 1 |
| Fleshner, P | 1 |
| Haagsman, AN | 1 |
| Kummeling, A | 1 |
| Moes, ME | 1 |
| Mesu, SJ | 1 |
| Kirpensteijn, J | 1 |
| Yang, C | 1 |
| Li, YL | 1 |
| Fang, J | 1 |
| Zhang, X | 1 |
| Liu, HP | 1 |
| Qin, XH | 1 |
| Xu, XP | 1 |
| Abeygunasekera, AM | 1 |
| de Silva, S | 1 |
| Gurusingha, A | 1 |
| Wijeratne, S | 1 |
| Merrick, GS | 1 |
| Butler, WM | 1 |
| Wallner, KE | 1 |
| Lief, JH | 1 |
| Galbreath, RW | 1 |
| Chapple, CR | 1 |
| Noble, JG | 1 |
| Milroy, EJ | 1 |
| Kumar, A | 1 |
| Banerjee, GK | 1 |
| Goel, MC | 1 |
| Mishra, VK | 1 |
| Kapoor, R | 1 |
| Bhandari, M | 1 |
| Woo, HH | 1 |
| Carmalt, HL | 1 |
| Ogbonna, BC | 1 |
| Okeahialam, BN | 1 |
| Ramyil, VM | 1 |
| de Mey, C | 1 |
| Michel, MC | 1 |
| McEwen, J | 1 |
| Moreland, T | 1 |
| Díaz Espiñeira, MM | 1 |
| Viehoff, FW | 1 |
| Nickel, RF | 1 |
| Miekos, E | 1 |
| Trzepizur, Z | 1 |
| Rózanski, W | 1 |
| Boniecki, R | 1 |
| Kusnierz, J | 1 |
| Jablonowski, Z | 1 |
| Zydek, C | 1 |
| Matzkin, H | 1 |
| Soloway, MS | 1 |
| Rangel, MC | 1 |
| Laddu, A | 1 |
| Petersen, MS | 1 |
| Collins, DN | 1 |
| Selakovich, WG | 1 |
| Finkbeiner, AE | 1 |
| Cataldo, PA | 1 |
| Senagore, AJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimal Duration of Urinary Catheterization After Total Mesorectal Excision[NCT04359069] | 176 participants (Anticipated) | Interventional | 2020-10-01 | Recruiting | |||
| Acute Urinary Retention After Early, Medium or Late Removal of the Urinary Catheter in Rectal Cancer Surgery. RAOREC Study[NCT04751149] | 143 participants (Anticipated) | Interventional | 2019-05-01 | Recruiting | |||
| Prospective Study Investigating Optimal Duration of Indwelling Urinary Catheter Following Infraperitoneal Colorectal Surgery and Role of Postoperative Alpha Blockade[NCT01923129] | 142 participants (Actual) | Interventional | 2012-11-30 | Completed | |||
| Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial[NCT03314025] | Phase 2 | 158 participants (Anticipated) | Interventional | 2017-10-06 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Urinary tract infection defined as symptomatic urinary complaints such as dysuria, with urinalysis consistent with infection. (NCT01923129)
Timeframe: During 1 week of hospitalization (prior to discharge)
| Intervention | Participants (Count of Participants) |
|---|---|
| 24 Hour Postop Catheter Removal | 0 |
| 72 Hour Postoperative Catheter Removal | 8 |
Acute urinary retention will be defined as catheter discontinuation with inability to void 6 hours post-removal, or void with post-void residual greater than 200 cc of urine. (NCT01923129)
Timeframe: Postoperative day 1 or postpoperative 3 depending on group randomization
| Intervention | Participants (Count of Participants) |
|---|---|
| 24 Hour Postop Catheter Removal | 6 |
| 72 Hour Postoperative Catheter Removal | 7 |
9 trials available for prazosin and Urinary Retention
| Article | Year |
|---|---|
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
[Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention].
Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Antihypertensive Agents; Double-Blind Method; Drug T | 2009 |
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; H | 2002 |
Comparative study of selective alpha 1-adrenoceptor blockade versus surgery in the treatment of prostatic obstruction.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Humans; Male; Middle Aged; Prazosin; Prostatectomy; Pr | 1993 |
A placebo controlled double blind study using perioperative prazosin in the prevention of urinary retention following inguinal hernia repair.
Topics: Acute Disease; Administration, Oral; Adrenergic alpha-Antagonists; Aged; Blood Pressure; Double-Blin | 1995 |
A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Blood Pressure; Blood Pressure Moni | 1998 |
The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial.
Topics: Adrenergic alpha-Antagonists; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Prazosin; | 2002 |
Efficacy of terazosin in patients with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Administration Schedule; Drug Evaluation; Humans; Male; Pra | 1992 |
Does alpha sympathetic blockade prevent urinary retention following anorectal surgery?
Topics: Anal Canal; Chi-Square Distribution; Double-Blind Method; Humans; Pain, Postoperative; Postoperative | 1991 |
7 other studies available for prazosin and Urinary Retention
| Article | Year |
|---|---|
Retrospective evaluation of prazosin and diazepam after thoracolumbar hemilaminectomy in dogs.
Topics: Adjuvants, Anesthesia; Animals; Diazepam; Dog Diseases; Dogs; Female; Intervertebral Disc Displaceme | 2019 |
Comparison of terazosin and prazosin for treatment of vesico-urethral reflex dyssynergia in dogs.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Dog Diseases; Dogs; Male; Prazosin; Treatment Outc | 2013 |
Management of men with a first episode of acute urinary retention due to benign prostatic enlargement.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prazosin; Prospect | 2001 |
Functional bladder neck obstruction: a rare cause of renal failure.
Topics: Adult; Catheters, Indwelling; Creatinine; Electromyography; Female; Follow-Up Studies; Humans; Kidne | 1995 |
alpha-receptor blockade for benign prostatic hyperplasia: uses and problems in a developing country.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Heart Diseases; Humans; Hypertension; Male; M | 1997 |
Idiopathic detrusor-urethral dyssynergia in dogs: a retrospective analysis of 22 cases.
Topics: Animals; Dog Diseases; Dogs; Male; Prazosin; Retrospective Studies; Sympatholytics; Treatment Outcom | 1998 |
Postoperative urinary retention associated with total hip and total knee arthroplasties.
Topics: Aged; Anesthesia; Hip Prosthesis; Humans; Incidence; Knee Prosthesis; Male; Middle Aged; Postoperati | 1991 |